Weight gain is one of the side effects that people who take antipsychotic drugs complain of the most. Obesity is common in this population and this can often lead to cardiovascular problems and a far shorter life expectancy than the rest of the population. As a result, there is a great deal of interest in [read the full story…]
There is an increasing body of evidence showing that depression and anxiety are linked with other health conditions like cancer and cardiovascular disease. I’ve blogged about the link between depression and stroke, and there are a number of other studies that show an association between psychological distress (the symptoms of depression and anxiety) and mortality, [read the full story…]
Back in February, I blogged about a cohort study published in the New England Journal of Medicine, which concluded that ADHD drugs are not linked with an increased risk of serious cardiovascular events. The last few years has seen heated debate about the use of central nervous stimulants in children and young people. The lack [read the full story…]
NICE published a clinical guideline on the treatment and management of depression in adults with chronic physical health problems in 2009. This new evidence update refreshes that guidance by searching for new systematic reviews and randomised controlled trials on the subject and summarising them in a short (16 page) document. The authors searched a range [read the full story…]
For many different reasons, people with schizophrenia and schizoaffective disorders have a greater risk of type 2 diabetes. The prevalence of type 2 diabetes in people with schizophrenia is twice that of the general population. This review looked for evidence of the efficacy of interventions to help people with schizophrenia manage their diabetes. Clinical question [read the full story…]
Research shows that rates of emotional and behavioural problems in deaf children are about twice as high as they are for hearing children. Depression and anxiety are common in deaf people and they face significant barriers to accessing mental heath services according to a new review in the Lancet. The review was carried out by [read the full story…]
The charity Rethink Mental Illness has launched a comprehensive range of new tools to help mental health professionals address the physical health needs of the people they work with. The tools have been developed as part of the 20 Years Too Soon campaign, which aims to raise awareness of the fact that people affected by [read the full story…]
A number of concerns have arisen over recent years about the safety of the various drugs used to treat ADHD (Attention Deficit Hyperactivity Disorder) in children and young adults. These central nervous system stimulants include methylphenidate, dexmethylphenidate, dextroamphetamines, amphetamine salts, atomoxetine and pemoline. Case reports have highlighted that sudden cardiac death can be brought on [read the full story…]
People with long-term conditions, such as diabetes or heart disease, are two to three times more likely to experience mental health problems than the general population. However, a systemic failure to identify these problems and provide effective support is resulting in poorer outcomes for patients and could be costing the NHS billions, says a report [read the full story…]
A multidisciplinary group of Dutch scientists have produced a guideline to help diagnose and treat medically unexplained physical symptoms (MUPS) and somatoform disorders (SD) in primary care, hospitals and occupational health settings. The guideline summarises the best available evidence and attempts to answer 4 key questions, for which the following findings are presented: 1. Preventive [read the full story…]
